Company Filing History:
Years Active: 2009-2011
Title: The Innovative Mind of Robert Droghini
Introduction
Robert Droghini, an accomplished inventor based in Candiac, Canada, stands out in the realm of pharmaceutical innovation. With a strong portfolio of two patents, he has made significant contributions to the development of novel compounds that have the potential to impact therapeutic advancements.
Latest Patents
Droghini’s recent work focuses on the "Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein." This patent outlines a method for synthesizing triazole substituted azaindoleoxoacetic piperazine derivatives. Furthermore, it introduces novel intermediates produced during the process and includes innovative N-1 and amorphous forms of these derivatives, along with methods for creating such forms.
Career Highlights
Currently, Robert Droghini is employed at Bristol-Myers Squibb Company, a leading biopharmaceutical company renowned for its commitment to innovation and research in drug development. His expertise in pharmaceutical innovation and his ability to bring new ideas to life through patenting processes make him a valuable asset to the organization.
Collaborations
In his career, Droghini has collaborated with talented colleagues such as Nachimuthu Soundararajan and Yuping Qiu. These collaborations enhance the innovative capacity of the team and contribute to the successful development of new pharmaceutical solutions.
Conclusion
Robert Droghini exemplifies the spirit of innovation within the pharmaceutical industry. His patents and collaborative efforts at Bristol-Myers Squibb Company highlight his dedication to creating novel solutions that have the potential to improve healthcare outcomes. As he continues to innovate, the impact of his work will likely resonate within the field for years to come.